{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:58:30Z","timestamp":1789721910464,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12016-013-8406-7","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T07:33:45Z","timestamp":1388648025000},"page":"65-72","source":"Crossref","is-referenced-by-count":55,"title":["Cogan's Syndrome\u2014Clinical Guidelines and Novel Therapeutic Approaches"],"prefix":"10.1007","volume":"47","author":[{"given":"Oshrat E.","family":"Tayer-Shifman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophir","family":"Ilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodaya","family":"Tovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"key":"8406_CR1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archopht.1945.00890140064007","volume":"33","author":"DS Cogan","year":"1945","unstructured":"Cogan DS (1945) Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 33:144\u2013149","journal-title":"Arch Ophthalmol"},{"key":"8406_CR2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00005792-198011000-00003","volume":"59","author":"BF Haynes","year":"1980","unstructured":"Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS (1980) Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 59:426\u2013441","journal-title":"Medicine (Baltimore)"},{"key":"8406_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0025-6196(12)61951-X","volume":"61","author":"RS Vollertsen","year":"1986","unstructured":"Vollertsen RS, McDonald TJ, Younge BR, Banks PM, Stanson AW, Ilstrup DM (1986) Cogan\u2019s syndrome: 18 cases and a review of the literature. Mayo Clin Proc 61:344\u2013361","journal-title":"Mayo Clin Proc"},{"key":"8406_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002281-199901000-00008","volume":"11","author":"EW St Clair","year":"1999","unstructured":"St Clair EW, McCallum RM (1999) Cogan\u2019s syndrome. Curr Opin Rheumatol 11:47\u201352","journal-title":"Curr Opin Rheumatol."},{"issue":"9337","key":"8406_CR5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(02)11028-2","volume":"360","author":"C Lunardi","year":"2002","unstructured":"Lunardi C, Bason C, Leandri M et al (2002) Autoantibodies to inner ear and endothelial antigens in Cogan\u2019s syndrome. Lancet 360(9337):915\u2013921","journal-title":"Lancet"},{"key":"8406_CR6","first-page":"572","volume":"72","author":"ER Fisher","year":"1961","unstructured":"Fisher ER, Hellstrom HR (1961) Cogan\u2019s syndrome and systemic vascular disease. Analysis of pathologic features with reference to its relationship to thromboangiitis obliterans (Buerger). Arch Pathol 72:572\u2013592","journal-title":"Arch Pathol"},{"key":"8406_CR7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4065\/81.4.483","volume":"81","author":"MB Gluth","year":"2006","unstructured":"Gluth MB, Baratz KH, Matteson EL, Driscoll CL (2006) Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 81:483\u2013488","journal-title":"Mayo Clin Proc"},{"key":"8406_CR8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/rheumatology\/keh228","volume":"43","author":"A Grasland","year":"2004","unstructured":"Grasland A, Pouchot J, Hachulla E, Bl\u00e9try O, Papo T, Vinceneux P (2004) Typical and atypical Cogan\u2019s syndrome: 32 cases and review of the literature. Rheumatology 43:1007\u20131015","journal-title":"Rheumatology"},{"key":"8406_CR9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0889-857X(21)01068-1","volume":"16","author":"RS Vollertsen","year":"1990","unstructured":"Vollertsen RS (1990) Vasculitis and Cogan\u2019s syndrome. Rheum Dis Clin North Am 16:433\u2013439","journal-title":"Rheum Dis Clin North Am"},{"key":"8406_CR10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1017\/S0022215100114264","volume":"104","author":"A Jacob","year":"1990","unstructured":"Jacob A, Ledingham JG, Kerr AI, Ford MJ (1990) Ulcerative colitis and giant cell arteritis associated with sensorineural deafness. J Laryngol Otol 104:889\u2013890","journal-title":"J Laryngol Otol"},{"key":"8406_CR11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0009-9260(05)81006-2","volume":"45","author":"HG Thomas","year":"1992","unstructured":"Thomas HG (1992) Case report: clinical and radiological features of Cogan\u2019s syndrome\u2014non-syphilitic interstitial keratitis, audiovestibular symptoms and systemic manifestations. Clin Radiol 45:418\u2013421","journal-title":"Clin Radiol"},{"key":"8406_CR12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/B978-0-323-06551-1.00162-7","volume-title":"Rheumatology","author":"EW St Clair","year":"2011","unstructured":"St Clair EW, McCallum RM (2011) Cogan\u2019s syndrome. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 5th edn. Mosby, Philadelphia, pp 1625\u20131634","edition":"5"},{"key":"8406_CR13","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s10067-007-0663-5","volume":"26","author":"H Balink","year":"2007","unstructured":"Balink H, Bruyn JA (2007) The role of PET\/CT in Cogan\u2019s syndrome. Clin Rheumatol 26:2177\u20132179","journal-title":"Clin Rheumatol"},{"key":"8406_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00129492-200303000-00012","volume":"24","author":"M Mazlumzadeh","year":"2003","unstructured":"Mazlumzadeh M, Lowe VJ, Mullan BP, Fabry DA, McDonald TJ, Matteson EL (2003) The utility of positron emission tomography in the evaluation of autoimmune hearing loss. Otol Neurotol 24:201\u2013204","journal-title":"Otol Neurotol"},{"key":"8406_CR15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00296-009-0945-0","volume":"29","author":"G Murphy","year":"2009","unstructured":"Murphy G, Sullivan MO, Shanahan F, Harney S, Molloy M (2009) Cogan\u2019s syndrome: present and future directions. Rheumatol Int 29:1117\u20131121","journal-title":"Rheumatol Int"},{"key":"8406_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/00016484409119921","volume":"32","author":"A Kleyn De","year":"1944","unstructured":"De Kleyn A (1944) Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol 32:407\u2013429","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"8406_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.otohns.2006.05.015","volume":"136","author":"JH Oh","year":"2007","unstructured":"Oh JH, Park K, Lee SJ, Shin YR, Choung YH (2007) Bilateral versus unilateral sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 136(1):87\u201391","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"12","key":"8406_CR18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2011.05.005","volume":"10","author":"A Greco","year":"2011","unstructured":"Greco A, Fusconi M, Gallo A, Marinelli C, Macri GF, De Vincentiis M (2011) Sudden sensorineural hearing loss: an autoimmune disease? Autoimmun Rev 10(12):756\u2013761","journal-title":"Autoimmun Rev"},{"key":"8406_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0194-5998(98)70324-9","volume":"118","author":"A Pitk\u00e4ranta","year":"1998","unstructured":"Pitk\u00e4ranta A, Julkunen I (1998) Sudden deafness: lack of evidence for systemic viral infection. Otolaryngol Head Neck Surg 118:397\u2013399","journal-title":"Otolaryngol Head Neck Surg"},{"key":"8406_CR20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.autrev.2012.07.012","volume":"12","author":"A Greco","year":"2012","unstructured":"Greco A, Gallo A, Fusconi M et al (2012) Cogan\u2019s syndrome: an autoimmune inner ear disease. Autoimmun Rev 12:396\u2013400","journal-title":"Autoimmun Rev"},{"issue":"10","key":"8406_CR21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.autrev.2012.01.004","volume":"11","author":"A Greco","year":"2012","unstructured":"Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M (2012) Meniere\u2019s disease might be an autoimmune condition? Autoimmun Rev 11(10):731\u2013738","journal-title":"Autoimmun Rev"},{"key":"8406_CR22","first-page":"3","volume":"113","author":"TJ Yoo","year":"1984","unstructured":"Yoo TJ, Tomoda K, Hernandez AD (1984) Type II collagen-induced autoimmune inner ear lesions in guinea pigs. Ann Otol Rhinol Laryngol Suppl 113:3\u20135","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"issue":"6","key":"8406_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2273.2000.00416.x","volume":"25","author":"MR Boulassel","year":"2000","unstructured":"Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M (2000) Identification of beta-actin as a candidate autoantigen in autoimmune inner ear disease. Clin Otolaryngol Allied Sci 25(6):535\u2013541","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"8","key":"8406_CR24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI200418195","volume":"113","author":"CA Solares","year":"2004","unstructured":"Solares CA, Edling AE, Johnson JM et al (2004) Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. J Clin Invest 113(8):1210\u20131217","journal-title":"J Clin Invest"},{"issue":"7","key":"8406_CR25","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1523\/JNEUROSCI.5063-03.2004","volume":"24","author":"TS Nair","year":"2004","unstructured":"Nair TS, Kozma KE, Hoefling NL et al (2004) Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72\u00a0kDa that is the target of antibody-induced hearing loss. J Neurosci 24(7):1772\u20131779","journal-title":"J Neurosci"},{"issue":"2","key":"8406_CR26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0049-0172(97)80010-8","volume":"27","author":"C Belizna","year":"1997","unstructured":"Belizna C, Tervaert JW (1997) Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. Semin Arthritis Rheum 27(2):98\u2013109","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"8406_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-0173(99)00075-2","volume":"32","author":"PP Lefebvre","year":"2000","unstructured":"Lefebvre PP, Van De Water TR (2000) Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 gene. Brain Res Brain Res Rev 32(1):159\u2013162","journal-title":"Brain Res Brain Res Rev"},{"issue":"1","key":"8406_CR28","first-page":"95","volume":"64","author":"Y Dong","year":"1994","unstructured":"Dong Y, Roos M, Gruijters T et al (1994) Differential expression of two gap junction proteins in corneal epithelium. Eur J Cell Biol 64(1):95\u2013100","journal-title":"Eur J Cell Biol"},{"key":"8406_CR29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0002-9343(90)90157-9","volume":"88","author":"NB Allan","year":"1990","unstructured":"Allan NB, Cox CC, Cobo M et al (1990) Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan\u2019s syndrome. Am J Med 88:296\u2013301","journal-title":"Am J Med"},{"issue":"10","key":"8406_CR30","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1073\/pnas.88.10.4220","volume":"88","author":"LJ Walsh","year":"1991","unstructured":"Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991) Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 88(10):4220\u20134224","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"8406_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","volume":"104","author":"RM Locksley","year":"2001","unstructured":"Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104(4):487\u2013501","journal-title":"Cell"},{"issue":"4","key":"8406_CR32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2106","volume":"16","author":"EA Said","year":"2010","unstructured":"Said EA, Dupuy FP, Trautmann L et al (2010) Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 16(4):452\u2013459","journal-title":"Nat Med"},{"issue":"5","key":"8406_CR33","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1084\/jem.184.5.1963","volume":"184","author":"IS Grewal","year":"1996","unstructured":"Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA (1996) Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J Exp Med 184(5):1963\u20131974","journal-title":"J Exp Med"},{"issue":"9","key":"8406_CR34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.autrev.2011.11.025","volume":"11","author":"C Comarmond","year":"2012","unstructured":"Comarmond C, Plaisier E, Dahan K et al (2012) Anti TNF-\u03b1 in refractory Takayasu\u2019s arteritis: cases series and review of the literature. Autoimmun Rev 11(9):678\u2013684","journal-title":"Autoimmun Rev"},{"key":"8406_CR35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00296-006-0252-y","volume":"27","author":"M Fricker","year":"2007","unstructured":"Fricker M, Baumann A, Wermelinger F, Villiger PM, Helbling A (2007) A novel therapeutic option in Cogan\u2019s disease? TNF-a blockers. Rheumatol Int 27:493\u2013495","journal-title":"Rheumatol Int"},{"key":"8406_CR36","first-page":"414","volume":"132","author":"D Aeberli","year":"2002","unstructured":"Aeberli D, Oertle S, Mauron H, Reichenbach S, Jordi B, Villiger PM (2002) Inhibition of the TNF pathway: use of infliximab and etanercept as remission inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Med Wkly 132:414\u2013422","journal-title":"Swiss Med Wkly"},{"key":"8406_CR37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00296-007-0373-y","volume":"27","author":"Z Touma","year":"2007","unstructured":"Touma Z, Nawwar R, Hadi U, Hourani M, Arayssi T (2007) The use of TNF-a blockers in Cogan\u2019s syndrome. Rheumatol Int 27:995\u2013996","journal-title":"Rheumatol Int"},{"key":"8406_CR38","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3899\/jrheum.080203","volume":"35","author":"R Ghadban","year":"2008","unstructured":"Ghadban R, Couret M, Zenone T (2008) Efficacy of infliximab in Cogan\u2019s syndrome. J Rheumatol 35:2456\u20132458","journal-title":"J Rheumatol"},{"key":"8406_CR39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1749-4486.2010.02180.x","volume":"35","author":"E Beccastrini","year":"2010","unstructured":"Beccastrini E, Emmi G, Squatrito D, Vannucchi P, Emmi L (2010) Infliximab and Cogan\u2019s syndrome. Clin Otolaryngol 35:441\u2013442","journal-title":"Clin Otolaryngol"},{"issue":"4","key":"8406_CR40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340(4):253\u2013259","journal-title":"N Engl J Med"},{"key":"8406_CR41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.21179","volume":"53","author":"EL Matteson","year":"2005","unstructured":"Matteson EL, Choi HK, Poe DS et al (2005) Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center open-label, pilot study. Arthritis Rheum 53:337\u2013342","journal-title":"Arthritis Rheum"},{"issue":"25","key":"8406_CR42","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JC Edwards","year":"2004","unstructured":"Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572\u20132581","journal-title":"N Engl J Med"},{"issue":"1","key":"8406_CR43","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar3224","volume":"13","author":"PP Tak","year":"2011","unstructured":"Tak PP, Kalden JR (2011) Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther 13(1):S5","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8406_CR44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amjmed.2011.09.010","volume":"125","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Sanz I, Bosch X, Stone JH, Khamashta MA (2012) B-cell-depleting therapy in systemic lupus erythematosus. Am J Med 125(4):327\u2013336","journal-title":"Am J Med"},{"issue":"1","key":"8406_CR45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/BOR.0b013e32834d5730","volume":"24","author":"R Cartin-Ceba","year":"2012","unstructured":"Cartin-Ceba R, Fervenza FC, Specks U (2012) Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab. Curr Opin Rheumatol 24(1):15\u201323","journal-title":"Curr Opin Rheumatol"},{"key":"8406_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000336188","volume":"51","author":"E Miserocchi","year":"2012","unstructured":"Miserocchi E, Modorati G (2012) Rituximab for noninfectious uveitis. Dev Ophthalmol 51:98\u2013109","journal-title":"Dev Ophthalmol"},{"key":"8406_CR47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1172-5-18","volume":"5","author":"JG Orsoni","year":"2010","unstructured":"Orsoni JG, Lagan\u00e0 B, Rubino P, Zavota L, Bacciu S, Mora P (2010) Rituximab ameliorated severe hearing loss in Cogan\u2019s syndrome: a case report. Orphanet J Rare Dis 5:18","journal-title":"Orphanet J Rare Dis"},{"key":"8406_CR48","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/lary.21060","volume":"120","author":"JR Wang","year":"2010","unstructured":"Wang JR, Yuen HW, Shipp DB et al (2010) Cochlear implantation in patients with autoimmune inner ear disease including cogan syndrome: a comparison with age- and sex-matched controls. Laryngoscope 120:2478\u20132483","journal-title":"Laryngoscope"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-013-8406-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-013-8406-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-013-8406-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T03:33:28Z","timestamp":1647833608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-013-8406-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["8406"],"URL":"https:\/\/doi.org\/10.1007\/s12016-013-8406-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,3]]}}}